microdosing tirzepatide for inflammation Program Tirzepatide Microdosing: The Growing Off-Label
Description
May 16, 2026- A new study from Veterans Affairs, published last month in JAMA Network Open, adds further weight to a growing body of evidence connecting GLP-1 medications to a heightened risk of non-arteritic anterior ischemic optic neuropathy, or NAION a condition in which damage to the optic nerve can cause symptoms ranging from mild vision disturbances to permanent blindness

Clinical pearl: Not everyone needs the maximum dose
First, there's the GLP-1 connection itself

Activities like walking, swimming, or cycling can improve your cardiovascular health

If you notice that your blood sugar levels are not as well controlled as before, or if you experience increased hunger or tiredness, let your doctor know

Monitor and manage side effects Keep track of all side effects and body changes you notice
